Engelhart James

Insider profile

Engelhart James's trades of Biohaven Pharmaceutical Holding Company Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-12-10 2021-12-10 PlS Planned sale
51,239 -33.8%
276.60
US$2,484,084
51,239 -33.8% 276.60 US$2,484,084
2021-12-10 2021-12-10 PlS Planned sale
10,857 +17.4%
383.60
US$3,136,123
10,857 +17.4% 383.60 US$3,136,123
2021-12-10 2021-12-10 PlS Planned sale
57,651 -49.5%
241.63
US$3,303,324
57,651 -49.5% 241.63 US$3,303,324
2020-06-12 2020-06-11 PlS Planned sale
2,452 -35.2%
64.85
US$159,015
2,452 -35.2% 64.85 US$159,015
2020-06-12 2020-06-11 PlS Planned sale
6,501 -48.2%
64.31
US$418,058
6,501 -48.2% 64.31 US$418,058
2020-06-12 2020-06-11 PlS Planned sale
4,847 -26.5%
63.19
US$306,286
4,847 -26.5% 63.19 US$306,286
2020-06-12 2020-06-11 PlS Planned sale
5,972 -24.6%
62.07
US$370,698
5,972 -24.6% 62.07 US$370,698
2020-06-12 2020-06-10 PlS Planned sale
300 -6.2%
68.07
US$20,420
300 -6.2% 68.07 US$20,420
2020-06-12 2020-06-10 PlS Planned sale
24,832 -83.7%
67.53
US$1,676,989
24,832 -83.7% 67.53 US$1,676,989
2020-06-12 2020-06-10 PlS Planned sale
28,821 -49.3%
66.66
US$1,921,136
28,821 -49.3% 66.66 US$1,921,136
2019-06-28 2019-06-27 B Purchase
2,500 +inf%
43.05
US$107,625
2,500 +inf% 43.05 US$107,625